Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

PCMA Says Competition Is Key to Lowering Drug Prices

  • Post author:Sam
  • Post published:January 29, 2019
  • Post category:Drug Industry Daily

Competition is the key to lower drug costs, the Pharmaceutical Care Management Association (PCMA) said in a letter to lawmakers in defense of pharmacy benefit managers. Source: Drug Industry Daily

Continue ReadingPCMA Says Competition Is Key to Lowering Drug Prices

Pharma Blasted in Congress for Manipulating Drug Prices

  • Post author:Sam
  • Post published:January 29, 2019
  • Post category:Drug Industry Daily

Drugmakers were conspicuously absent on Tuesday from two drug pricing hearings on Capitol Hill, where lawmakers called out big pharma for setting high drug prices through manipulative means — and…

Continue ReadingPharma Blasted in Congress for Manipulating Drug Prices

NY Pharmacists: PBMs Hiked Generics Prices in Medicaid Managed Care Program

  • Post author:Sam
  • Post published:January 28, 2019
  • Post category:Drug Industry Daily

A New York pharmacist group claims the misuse of “spread pricing” by the state’s pharmacy benefit managers has led to increased drug prices – especially for generics. Source: Drug Industry…

Continue ReadingNY Pharmacists: PBMs Hiked Generics Prices in Medicaid Managed Care Program

PhRMA Pushes Back on CMS Plan to Increase Medicare Part D, Advantage Negotiating Power

  • Post author:Sam
  • Post published:January 28, 2019
  • Post category:Drug Industry Daily

PhRMA picked holes in a proposed Centers for Medicare & Medicaid Services rule increasing Medicare Advantage and Part D plans’ power to negotiate drug prices. Source: Drug Industry Daily

Continue ReadingPhRMA Pushes Back on CMS Plan to Increase Medicare Part D, Advantage Negotiating Power

Gottlieb Touts FDA’s Plans for Real-World Evidence in Trials

  • Post author:Sam
  • Post published:January 28, 2019
  • Post category:Drug Industry Daily

FDA Commissioner Scott Gottlieb on Monday outlined the agency’s plans for promoting the use of real world evidence in clinical trials in 2019. Source: Drug Industry Daily

Continue ReadingGottlieb Touts FDA’s Plans for Real-World Evidence in Trials

Controls Found Lacking at Contract Manufacturer Thatcher

  • Post author:Sam
  • Post published:January 11, 2019
  • Post category:The GMP Letter

Contract manufacturer Thatcher Company failed to exercise appropriate controls over computers and related systems to assure that changes in production were only instituted by authorized personnel, FDA inspectors found during…

Continue ReadingControls Found Lacking at Contract Manufacturer Thatcher

Surgical Instruments Maker Racks Up 11-Item 483

  • Post author:Sam
  • Post published:January 11, 2019
  • Post category:The GMP Letter

Lax medical device reporting and CAPA procedures as well as a host of other quality issues were uncovered during a July 31 to Aug. 2 FDA inspection of LED Intellectual…

Continue ReadingSurgical Instruments Maker Racks Up 11-Item 483

Texas Neonatal Devicemaker Falls Short on Process Controls

  • Post author:Sam
  • Post published:January 11, 2019
  • Post category:The GMP Letter

FDA inspectors found shoddy process controls and a lack of validation documentation in a Sept. 17 to Sept. 21 inspection of Footprint Medical’s San Antonio, Texas facility. Source: The GMP…

Continue ReadingTexas Neonatal Devicemaker Falls Short on Process Controls

Canada Issues Guidance on Cybersecurity Requirements

  • Post author:Sam
  • Post published:January 11, 2019
  • Post category:The GMP Letter

Health Canada released guidance for devicemakers on how to comply with premarket cybersecurity requirements. Source: The GMP Letter

Continue ReadingCanada Issues Guidance on Cybersecurity Requirements

Device Groups Reject Media Reports of Inadequate Oversight

  • Post author:Sam
  • Post published:January 11, 2019
  • Post category:The GMP Letter

International medical device associations rejected a recent report by the International Consortium of Investigative Journalists (ICIJ), which pointed to inadequate oversight of devices globally. Source: The GMP Letter

Continue ReadingDevice Groups Reject Media Reports of Inadequate Oversight
  • Go to the previous page
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.